Company news
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. news in 2021
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'s news releases, calls and decks from 2021, newest first.
Resignation of vice chairman and executive director
May 6, 2021
Shenzhen Hepalink Pharmaceutical Group: Voluntary announcement"heptris" obtains approval from brazilian health regulatory agency
April 21, 2021
(1) Resignation of non-executive director (2) proposed appointment of executive director
April 20, 2021
Shenzhen Hepalink Pharmaceutical Group: Voluntary announcement - "inhixa" obtains approval from north macedonia
April 13, 2021
Voluntary announcement settlement of the disposal of shares of kymab
April 9, 2021